Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Alogliptin ups risk of heart failure exacerbation in T2D patients

Alogliptin ups risk of heart failure exacerbation in T2D patients

13 Mar 2024

In type 2 diabetes (T2D) patients with established heart failure (HF), use of alogliptin appears to contribute to an increased risk of HF exacerbation, reveals a study.

Alogliptin ups risk of heart failure exacerbation in T2D patients

13 Mar 2024